Menopearl

Menopearl comes in the form of film-coated tablets, packaged in blister packs, each tablet containing a precise and standardised dose of 80 mg of MF11RCE® red clover isoflavones and 120 mg of hyaluronic acid.

The pharmaceutical form allows for easy administration and ensures increased bioavailability of the active ingredients, thus contributing to the therapeutic efficacy of the product.

Menopearl is recommended for women in perimenopause, menopause or postmenopause who wish to manage the symptoms typical of this hormonal transition period.

The main indications include: reduction of hot flushes and night sweats, improvement of sleep disorders, reduction of anxiety and depressive states, increase in libido, combating vaginal dryness and supporting the general condition of the skin and hair.

Menopearl is also recommended for women who avoid conventional hormone therapies due to contraindications or personal preferences for natural therapies.

The recommended dose is 1 tablet per day, taken with a little water, preferably during or immediately after a meal.

To achieve beneficial effects, continuous administration for at least 2 months is necessary.

It is important to note that the effect is not immediate, as it takes time for the body to integrate the active ingredients and manifest the desired response.

Menopearl is contraindicated in cases of known hypersensitivity to any of the product's ingredients.

If you suffer from hormone-sensitive conditions such as breast cancer, uterine cancer, ovarian cancer, endometriosis or uterine fibroids, consult your doctor before use.

Pregnant and breastfeeding women should avoid taking this product, as there is insufficient clinical data to confirm its safety for use in these populations.

Menopearl is a product that is distinguished by the complete absence of animal-derived ingredients and lactose, making it suitable for people with lactose intolerance or those who follow a vegetarian diet.

It should be noted that the isoflavones in MF11RCE® are carefully extracted from red clover plants grown in the European Union in accordance with GAP standards, and the manufacturing process takes place in Austria under strict GMP regulations, thus guaranteeing the purity and superior quality of the product.

Clinical studies have shown that Menopearl is very well tolerated, with no significant adverse effects.

In rare cases, minor gastrointestinal reactions such as mild nausea or bloating may occur, which disappear spontaneously. People with individual sensitivity to plants of the Fabaceae (legume) family may experience allergic reactions, so medical advice should be sought if unusual symptoms occur during use.

To date, no significant interactions of Menopearl with other medicines or foods have been reported.

However, patients undergoing anticoagulant therapy, hormone medication or cancer treatment should consult their doctor before starting to take this product to avoid possible interactions.

No cases of overdose with Menopearl have been reported. However, as a general safety measure, it is not recommended to exceed the indicated daily dose.

In the event of accidental ingestion of a multiple dose, symptomatic monitoring and medical advice are recommended, especially if digestive or allergic reactions occur.

Menopearl should be stored at room temperature, in a dry place, away from direct light and heat sources. Keep out of the reach of children. Observe the expiry date stated on the packaging.

• PubMed, Effects of a red clover extract (MF11RCE) on the endometrium and sex hormones in postmenopausal women
• WebMD, Red clover
• Healthline, Red clover: Benefits, uses and side effects
• Mount Sinai, Red clover